Brokerages Set Intuitive Surgical, Inc. (NASDAQ:ISRG) Price Target at $554.17

Intuitive Surgical, Inc. (NASDAQ:ISRG) has been assigned a consensus recommendation of “Moderate Buy” from the nineteen ratings firms that are presently covering the company, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and fifteen have assigned a buy recommendation to the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $554.17.

Several research firms recently issued reports on ISRG. Mizuho lifted their price objective on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. BTIG Research increased their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, November 26th. Robert W. Baird lifted their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Finally, JPMorgan Chase & Co. increased their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $535.29 on Thursday. The stock has a 50 day simple moving average of $532.76 and a 200-day simple moving average of $490.65. Intuitive Surgical has a 1-year low of $320.26 and a 1-year high of $556.23. The company has a market cap of $190.66 billion, a price-to-earnings ratio of 86.06, a PEG ratio of 5.31 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Analysts anticipate that Intuitive Surgical will post 5.45 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, SVP Mark Brosius sold 2,128 shares of the business’s stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the sale, the senior vice president now owns 273 shares of the company’s stock, valued at $140,595. The trade was a 88.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock valued at $25,012,927 over the last quarter. 0.90% of the stock is owned by insiders.

Hedge Funds Weigh In On Intuitive Surgical

Several hedge funds have recently bought and sold shares of ISRG. Convergence Investment Partners LLC purchased a new stake in Intuitive Surgical during the second quarter worth about $200,000. Legacy Capital Wealth Partners LLC acquired a new position in shares of Intuitive Surgical in the second quarter valued at approximately $411,000. Midland Wealth Advisors LLC acquired a new position in shares of Intuitive Surgical in the second quarter valued at approximately $246,000. Novare Capital Management LLC purchased a new stake in Intuitive Surgical during the 2nd quarter worth approximately $219,000. Finally, Oregon Public Employees Retirement Fund boosted its position in Intuitive Surgical by 1.2% in the 2nd quarter. Oregon Public Employees Retirement Fund now owns 30,495 shares of the medical equipment provider’s stock valued at $13,566,000 after buying an additional 362 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.